Skip to content
naulon
Not checkedNot checked for notices yet.

The 3D Printed Total Talus Replacement: A Novel Treatment Option for Avascular Necrosis of the Talus

Rishin J. Kadakia MD, Craig C. Akoh MD, Jie Chen MD, MPH and 2 more

Foot & Ankle Orthopaedics · 2020

doi:10.1177/2473011420s00274 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Category: Ankle; Trauma Introduction/Purpose: Talus avascular necrosis (AVN) is a challenging entity to treat. Management options depend upon disease stage and severity. Total talus replacement (TTR) is a treatment option that maintains joint range of motion. The literature on TTR is limited with variability in implant design and material. The purpose of this study is to evaluate outcomes following total talus replacement with a custom 3D printed metal implant. Methods: Patients that underwent TTR were retrospectively reviewed over a three year period. Basic demographic data and comorbidities were collected. Medical records were reviewed to obtain postoperative and preoperative visual analog (VAS) scores, Foot and Ankle Outcomes Scores, (FAOS), ankle range of motion, and postoperative complications. Statistical analysis was conducted to compare clinical and patient-reported outcomes pre and postoperatively. Results: Twenty-eight patients underwent TTR for talar AVN with a mean follow-up of 16.4 months. Ankle range of motion remained unchanged statistically pre and postoperatively. VAS pain scores improved significantly pre and postoperative from 6.6 to 3.9 (p < 0.001). FAOS scores significantly improved postoperatively with regards to pain (p = 0.002), symptoms (p=0.03), quality of life (p < 0.001), and activities of daily living (P < 0.001). There were three complications requiring reoperation in this cohort. Conclusion:: 3D printed total talus replacements represent a unique surgical option for patients with talar collapse secondary to AVN. Patients in this cohort demonstrated significant improvements in pain scores and patient-reported outcomes while maintaining preoperative joint range of motion. TTR allows for symptomatic improvement with the preservation of motion in individuals with talar collapse and end-stage AVN.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.